Disease foundations fret as biotechs suffer - Boston Business Journal:

vanbeekdulejos1771.blogspot.com
Disease foundations have become an increasinglgy important part of the funding strategty for companieswith early-stage drug targets, because foundations will often fund an interesting technology that has a hard time gettinf venture capitalists to take the plunge. As capitapl markets have become tighter, the disease foundations have becomre a lifeline in some Foundations are being squeezed by companies that need supporyt for longer periodsof time, and face threats that breakthroughb therapies could be stranded by publi c and private markets that don’tf always reward the best science.